Latest News

Two Ebola treatments yield ‘substantial decrease’ in mortality, landmark trial shows

Final data from a landmark clinical trial of four Ebola therapies conducted in the current outbreak in the Democratic Republic of the Congo show two of the drugs dramatically reduced the risk of dying from the disease, especially in people who started treatment quickly after onset of their illness.

Findings of the PALM trial, published in the New England Journal of Medicine on Wednesday, show that two treatments based on Ebola antibodies led to a survival rate of about 65% in treated patients, compared to 33% in the outbreak overall.

Read the rest…

Source link

Related posts

Study finds maternal race not a factor for children experiencing a 'language gap'


Medical News Today: What to know about herniated disc surgery


Home-Cooked Meals Linked to Lower PFAS in the Body


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy